Matthew E. Korenberg - Feb 15, 2024 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
PRESIDENT & CHIEF OPERATING
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Matthew E. Korenberg
Stock symbol
LGND
Transactions as of
Feb 15, 2024
Transactions value $
-$356,678
Form type
4
Date filed
2/16/2024, 08:10 PM
Previous filing
Jan 4, 2024
Next filing
Feb 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$357K -4.78K -5.07% $74.65 89.4K Feb 15, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.